Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 996 results for "glenmark"

Buy Glenmark, target Rs 914: AK Prabhakar

AK Prabhakar Head of Research, IDBI Capital recommends a buy rating on Glenmark with a target price of Rs 914 and a strict stop loss placed at Rs 858. The stock has gained 5 per cent so far in the calendar year 2016. The stock is looking bullish on ... Economic Times, 1 day ago
Buy Glenmark, target Rs 920: Ashish Kyal Economic Times, 4 days ago

30 images for glenmark

Business Standard, 6 days ago
Moneycontrol.com, 5 days ago
Financial Express, 6 days ago
Livemint.com, 1 week ago
India Infoline, 1 week ago
DNA, 3 days ago
Unlimited Magazine, 1 week ago
Times of India, 5 days ago
Moneycontrol.com, 1 week ago
DNA India, 1 week ago
Times of India

Glenmark Pharmaceuticals launches 'Digihaler'

India, May 26 -- Glenmark Pharmaceuticals has launched Digihaler, a Digital Dose Inhaler (DDI). This next-gen inhaler provides accurate digital dose counter along with low dose warning indicator to enable asthma and chronic obstructive pulmonary ...
 HT Syndication5 days ago Glenmark launches digital inhaler for asthma, obstructive pulmonary disease  Livemint.com6 days ago Glenmark to ramp up respiratory business with new inhaler  Smart Investor6 days ago Glenmark launches digital dose inhaler for asthma patients  Business Standard6 days ago
[x]  
India Infoline

Glenmark Pharmaceuticals advances on launching 'Digihaler'

India, May 26 -- Glenmark Pharmaceuticals is currently trading at Rs. 861.00, up by 1.25 points or 0.15% from its previous closing of Rs. 859.75 on the BSE.The scrip opened at Rs. 862.30 and has touched a high and low of Rs. 862.55 and Rs. 859.65 ...
 HT Syndication5 days ago Glenmark Pharmaceuticals receives ANDA approval for Rufinamide Tablets USP, 200 mg and 400 mg  Equity Bulls5 days ago Buy Glenmark Pharma, UPL; sell Sun TV: Ashwani Gujral  Money Control1 week ago Glenmark Pharma receives USFDA nod for Rufinamide tablets  Myiris1 week ago
[x]  

Glenmark launches electronic inhaler for asthma patients

Glenmark Pharmaceuticals has launched Digihaler" a device which is an electronic inhaler for asthma patients. This inhaler provides accurate digital dose counter along with low dose warning indicator to enable Asthma and chronic obstructive pulmonary disease ...
 Business Line6 days ago Glenmark launches measurable inhaler for asthma, COPD patients  Nerve6 days ago
[x]  
DNA

Pick Glenmark Pharma, Alembic Pharmaceuticals: Mehraboon Irani

Mehraboon Irani of Nirmal Bang Securities is of the view that Glenmark Pharma and Alembic Pharmaceuticals are the best picks from the pharma space.
 Money Control1 week ago 'Glenmark to profit from drug price hike, +ve on Sun Pharma'  Money Control4 weeks ago Glenmark, Aurobindo, Jubilant top picks in pharma: Prabhudas  Money Control1 month ago Sell Glenmark Pharma, says CA Rudramurthy BV  Money Control1 month ago
[x]  

Glenmark Pharmaceuticals submits copy of press release

Industry: Medical/Healthcare Company Glenmark Pharmaceuticals Ltd Glenmark Pharmaceuticals has submitted a copy of Press Release dated May 19, 2016 titled Glenmark Pharmaceuticals receives ANDA approval for Rufinamide Tablets USP, 200 mg and ...
 Finalaya.com1 week ago Earnings Call (SCRIPCODE: 532296)  HT Syndication3 weeks ago
Livemint.com

Glenmark gets FDA final approval to sell anti-epileptic drug in US

USFDA has granted approval for the tablets in 200 and 400 milligram dosage forms Hyderabad: Glenmark Pharmaceuticals Ltd. on Thursday said it has received final approval to sell its anti-epileptic drug in the US, after a tentative approval received ...
 Livemint.com1 week ago
Business Standard India

India and US business continue to grow over 20%: Glenn Saldanha

Glenn Saldanha Glenmark Pharmaceuticals had a Rs 143 crore net profit in the March quarter, with strong revenue growth from all markets. Glenn Saldanha , chairman and managing director, talks to Aneesh Phadnis on the details. Edited excerpts: ...
 Business Standard India2 weeks ago India, US businesses growing over 20%: Glenn Saldanha  Smart Investor2 weeks ago Glenmark Q4 net profit surges 13-fold to Rs 143 cr  Business Standard2 weeks ago Glenmark Q4 net seen at Rs 200cr, weak LatAm biz may hurt sales  Money Control2 weeks ago
[x]  
Financial Express

Nestle India, Glenmark Pharma among 10 stocks in focus

The BSE Sensex and NSE Nifty opened weak on Friday after industrial production plunged to 0.1 per cent in March amidweak global cues.At 9.24 am, Sensex was trading 75.34 points down at 25,714.88, while NSE Nifty was trading 24.65 points down at ...
 MSN News US1 week ago Nestle India, Glenmark Pharma, Indian Bank among 10 stocks in focus in Friday's trade  Financial Express2 weeks ago Glenmark, Nestle, Polaris in focus post their Q4 nos  Money Control2 weeks ago Dr.Reddy's Laboratories,Glenmark Pharma results in focus  India Infoline2 weeks ago
[x]  

SP Tulsian's views on Glenmark, NBFC space and PSUs

SP Tulsian, sptulsian.com, shares his views on Glenmark, PSU bank stocks and why he is bearish on NBFC stocks.
 Money Control2 weeks ago Enter Glenmark Pharma, says SP Tulsian  Money Control2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - glenmark
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less